Omer Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omer Yilmaz has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Caner Ediz
Sultan Abdulhamid Han Egitim ve Arastirma Hastanesi
10 shared publications - Serkan Akan
Department of Urology University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital Istanbul Turkey
8 shared publications - Hasan Hüseyin Tavukçu
Department of Urology University of Health SciencesSultan Abdulhamid Han Training and Research Hospital Istanbul Turkey
4 shared publications - Muhammed Cihan Temel
Department of Urology, Nevsehir State Hospital, Nevsehir, Turkey
4 shared publications - Yunus Emre Kızılkan
Department of Urology University of Health SciencesSultan Abdulhamid Han Training and Research Hospital Istanbul Turkey
4 shared publications - Mehmet Pehlivanoğlu
Department of Urology, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 3
Radiodensity as a predictor: can penile and splenic Hounsfield units forecast clinical response to daily tadalafil?
Background: Objective imaging biomarkers reflecting penile microvascular perfusion in erectile dysfunction are limited. Hounsfield unit measurements obtained from non-contrast computed tomography may offer a non-invasive approach to assess tissue perfusion. This retrospective cohort study evaluated the associations between penile and splenic tissue density values and erectile function scores, and explored their relationship with response to daily tadalafil therapy. Results: A total of 194 men with erectile dysfunction who underwent non-contrast lower abdominal computed tomography were included. Tissue density values were measured in proximal, midshaft, and distal penile segments as well as in splenic parenchyma. Daily tadalafil 5 mg was associated with statistically significant improvements across erectile function domains (mean change in erectile function score: +7.9 points; p < 0.0001). Baseline penile tissue density values demonstrated positive correlations with splenic tissue density, suggesting a potential association related to perfusion characteristics. Although responders exhibited lower baseline tissue density values in selected penile segments compared with non-responders, these parameters did not independently predict treatment response in multivariable analysis. Conclusions: Computed tomography–derived tissue density measurements of penile and splenic tissues may offer complementary, objective information related to tissue perfusion in men with erectile dysfunction. While these findings support the exploratory use of imaging-based density analysis in understanding vascular and metabolic influences on erectile function, prospective multicentre studies with standardized protocols are required to validate their clinical utility.
- 11 February 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 3
Open AccessRadiodensity as a predictor: can penile and splenic Hounsfield units forecast clinical response to daily tadalafil?
Background: Objective imaging biomarkers reflecting penile microvascular perfusion in erectile dysfunction are limited. Hounsfield unit measurements obtained from non-contrast computed tomography may offer a non-invasive approach to assess tissue perfusion. This retrospective cohort study evaluated the associations between penile and splenic tissue density values and erectile function scores, and explored their relationship with response to daily tadalafil therapy. Results: A total of 194 men with erectile dysfunction who underwent non-contrast lower abdominal computed tomography were included. Tissue density values were measured in proximal, midshaft, and distal penile segments as well as in splenic parenchyma. Daily tadalafil 5 mg was associated with statistically significant improvements across erectile function domains (mean change in erectile function score: +7.9 points; p < 0.0001). Baseline penile tissue density values demonstrated positive correlations with splenic tissue density, suggesting a potential association related to perfusion characteristics. Although responders exhibited lower baseline tissue density values in selected penile segments compared with non-responders, these parameters did not independently predict treatment response in multivariable analysis. Conclusions: Computed tomography–derived tissue density measurements of penile and splenic tissues may offer complementary, objective information related to tissue perfusion in men with erectile dysfunction. While these findings support the exploratory use of imaging-based density analysis in understanding vascular and metabolic influences on erectile function, prospective multicentre studies with standardized protocols are required to validate their clinical utility.
- Open Access
- 7 February 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (1) , 10-14
Comparative analysis of human telomerase reverse transcriptase mutation in transitional epithelial cell bladder cancer in high and low grade tumors
Aims: We aimed to evaluate the presence of TERT promoter region mutations in transitional epithelial cell bladder cancer by analyzing the h-TERT mutation in high and low-grade tumors and to compare it with the clinicopathological data of the patients. Methods: A total of 90 patients diagnosed with bladder cancer, 60 with low-grade tumors and 30 with high-grade tumors were included in this study. To detect mutations in the TERT gene in the DNA samples obtained, the most frequently mutated region of the gene was amplified by PCR using forward and reverse primers and mutation analysis was performed by sequence analysis. Results: TERT promoter mutation was positive in 38 and negative in 22 out of 60 patients in the low grade group, and positive in 26 and negative in 4 out of 30 patients in the high grade group. Patients with high-grade tumors were 1.940 times more likely to be TERT promoter mutation positive than low-grade patients (p=0.027) Conclusion: When interpreted together with other studies that have obtained significant results that TERT mutation analysis can be used in diagnosis, tumor grading and follow-up, it is thought that it can be used in the grading and follow-up algorithm.
- 7 February 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (1) , 10-14
Open AccessComparative analysis of human telomerase reverse transcriptase mutation in transitional epithelial cell bladder cancer in high and low grade tumors
Aims: We aimed to evaluate the presence of TERT promoter region mutations in transitional epithelial cell bladder cancer by analyzing the h-TERT mutation in high and low-grade tumors and to compare it with the clinicopathological data of the patients. Methods: A total of 90 patients diagnosed with bladder cancer, 60 with low-grade tumors and 30 with high-grade tumors were included in this study. To detect mutations in the TERT gene in the DNA samples obtained, the most frequently mutated region of the gene was amplified by PCR using forward and reverse primers and mutation analysis was performed by sequence analysis. Results: TERT promoter mutation was positive in 38 and negative in 22 out of 60 patients in the low grade group, and positive in 26 and negative in 4 out of 30 patients in the high grade group. Patients with high-grade tumors were 1.940 times more likely to be TERT promoter mutation positive than low-grade patients (p=0.027) Conclusion: When interpreted together with other studies that have obtained significant results that TERT mutation analysis can be used in diagnosis, tumor grading and follow-up, it is thought that it can be used in the grading and follow-up algorithm.
- Open Access
- 1 November 2022
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 48 (6) , 431-439
Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney
Objective: Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephroureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer. Material and methods: Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ureterorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were associated with intravesical recurrence-free survival. Results: Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free survival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterorenoscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location. Conclusion: Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed. Cite this article as: Culpan M, Cakici MC, Keser F, et al. Biopsy with ureterorenoscopy before radical nephroureterectomy is associated with increased intravesical recurrence in urothelial cancer located in the kidney. Turk J Urol. 2022;48(6):431-439.
- 1 November 2022
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 48 (6) , 431-439
Open AccessBiopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney
Objective: Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephroureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer. Material and methods: Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ureterorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were associated with intravesical recurrence-free survival. Results: Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free survival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterorenoscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location. Conclusion: Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed. Cite this article as: Culpan M, Cakici MC, Keser F, et al. Biopsy with ureterorenoscopy before radical nephroureterectomy is associated with increased intravesical recurrence in urothelial cancer located in the kidney. Turk J Urol. 2022;48(6):431-439.
- Open Access
- 19 September 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (8) , 1084-1089
Urethral monopolar cauterization: alternative infravesical obstruction model in male rats
OBJECTIVE: We aimed to determine which method gives the most consistent results between urethral monopolar cauterization and standard urethral partial ligation methods for the urethral obstruction model.METHODS: Thirty male rats were randomly divided into control, partial ligation, and monopolar cauterization groups. Six weeks after experimental procedures, the experimental groups were evaluated cystometrically, biochemically, and histologically.RESULTS: According to the cystometric results, bladder capacity, baseline bladder pressure, and compliance data of the monopolar cauterization group were higher than those of the partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). As a biochemical evaluation, malondialdehyde levels in bladder tissues of group control were higher than partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). The collagen type I level of the control group was higher than the partial ligation and monopolar cauterization groups (p<0.01 and p<0.05, respectively). Collagen type III levels of the monopolar cauterization group were higher than those of the control group (p<0.01), but the Collagen type I/Collagen type III and transforming growth factor-beta levels of the monopolar cauterization group were significantly lower than those of the control group (p<0.001). As a histological evaluation (hematoxylin and eosin), fibrosis in the lamina propria was more prominent in the monopolar cauterization group than in the control group (p<0.05). In addition, the muscular thickness was higher in the monopolar cauterization group compared with control and partial ligation groups (p<0.001 and p<0.01, respectively).CONCLUSION: The needle-tipped monopolar cauterization of the posterior urethra may be the method of choice for creating a chronic infravesical obstruction model of infravesical obstruction in male rats.
- 19 September 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (8) , 1084-1089
Open AccessUrethral monopolar cauterization: alternative infravesical obstruction model in male rats
OBJECTIVE: We aimed to determine which method gives the most consistent results between urethral monopolar cauterization and standard urethral partial ligation methods for the urethral obstruction model.METHODS: Thirty male rats were randomly divided into control, partial ligation, and monopolar cauterization groups. Six weeks after experimental procedures, the experimental groups were evaluated cystometrically, biochemically, and histologically.RESULTS: According to the cystometric results, bladder capacity, baseline bladder pressure, and compliance data of the monopolar cauterization group were higher than those of the partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). As a biochemical evaluation, malondialdehyde levels in bladder tissues of group control were higher than partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). The collagen type I level of the control group was higher than the partial ligation and monopolar cauterization groups (p<0.01 and p<0.05, respectively). Collagen type III levels of the monopolar cauterization group were higher than those of the control group (p<0.01), but the Collagen type I/Collagen type III and transforming growth factor-beta levels of the monopolar cauterization group were significantly lower than those of the control group (p<0.001). As a histological evaluation (hematoxylin and eosin), fibrosis in the lamina propria was more prominent in the monopolar cauterization group than in the control group (p<0.05). In addition, the muscular thickness was higher in the monopolar cauterization group compared with control and partial ligation groups (p<0.001 and p<0.01, respectively).CONCLUSION: The needle-tipped monopolar cauterization of the posterior urethra may be the method of choice for creating a chronic infravesical obstruction model of infravesical obstruction in male rats.
- 1 March 2022
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 9 (1) , 33-39
A Novel Survey of the Treatment Trends and Technical Details for Extracorporeal Shockwave Lithotripsy From Experienced European Endourologists
- 1 March 2022
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 9 (1) , 33-39
A Novel Survey of the Treatment Trends and Technical Details for Extracorporeal Shockwave Lithotripsy From Experienced European Endourologists
- 17 May 2021
- Published by Taylor & Francis in Cancer Investigation
- Vol. 39 (6-7) , 521-528
Correlation of the Grade Group of Prostate Cancer according to the International Society of Urological Pathology (Isup) 2014 Classification between Prostate Biopsy and Radical Prostatectomy Specimens
Abtract We aimed to assess the correlation between ISUP 2014 grades of needle biopsy (NB) and radical prostatectomy (RP) specimens and the parameters effecting this correlation. A total of 353 patients, who underwent a radical prostatectomy with diagnose of prostate cancer, were included in the study. Especially, the maximum percentage of core involved by cancer (MPCI) of upgraded group was significantly higher than those of correlated group and downgraded group. MPCI might be used as a preoperative value to determine risk classification and to help counsel patients with regard to treatment decision and prognosis of disease.
- 17 May 2021
- Published by Taylor & Francis in Cancer Investigation
- Vol. 39 (6-7) , 521-528
Correlation of the Grade Group of Prostate Cancer according to the International Society of Urological Pathology (Isup) 2014 Classification between Prostate Biopsy and Radical Prostatectomy Specimens
Abtract We aimed to assess the correlation between ISUP 2014 grades of needle biopsy (NB) and radical prostatectomy (RP) specimens and the parameters effecting this correlation. A total of 353 patients, who underwent a radical prostatectomy with diagnose of prostate cancer, were included in the study. Especially, the maximum percentage of core involved by cancer (MPCI) of upgraded group was significantly higher than those of correlated group and downgraded group. MPCI might be used as a preoperative value to determine risk classification and to help counsel patients with regard to treatment decision and prognosis of disease.
- Open Access
- 1 March 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (3) , e13752
COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy
Aim We evaluated the COVID-19 infection threat in patients receiving intravesical BCG therapy which has immunotherapeutic effects and is of vital importance in most of the individuals with high-risk non-muscle-invasive bladder cancer (NMIBC) and investigated the need for postponement of this therapy. Methods A total of 71 patients, who were diagnosed with high-risk NMIBC and on intravesical BCG treatment regularly (induction or maintenance), were enrolled in the study. The patients were classified into two groups depending on whether they were diagnosed with COVID-19 during the pandemic period or not. Results Of 71 patients, 26 underwent a COVID-19 polymerase chain reaction test with clinical suspicion during the pandemic period. Of these 26 patients, 4 were diagnosed with COVID-19. Age of the patients, working status (working/retired), compliance with containment measures against the pandemic, number of BCG courses, adverse effects after BCG therapy and systemic immune-inflammation index, which is an inflammation-related parameter, were not different between groups (P > .05). Neutrophil/lymphocyte ratio was significantly higher in the COVID-19 positive group (P < .05). COVID-19 positivity was higher in age groups 50-64 (6.6%) and 65-80 (5.8%) years than that in similar age groups of the normal population. Conclusion Every effort should be made to administer intravesical BCG treatment in high-risk NMIBC patients even during the pandemic period. However, increased risk of COVID-19 transmission should be kept in mind and protective measures against COVID-19 for healthcare providers and patients before the procedure should be taken optimally. The procedure should be postponed in patients with lymphopenia in recent complete blood count.
- 1 March 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (3) , e13752
Open AccessCOVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy
Aim We evaluated the COVID-19 infection threat in patients receiving intravesical BCG therapy which has immunotherapeutic effects and is of vital importance in most of the individuals with high-risk non-muscle-invasive bladder cancer (NMIBC) and investigated the need for postponement of this therapy. Methods A total of 71 patients, who were diagnosed with high-risk NMIBC and on intravesical BCG treatment regularly (induction or maintenance), were enrolled in the study. The patients were classified into two groups depending on whether they were diagnosed with COVID-19 during the pandemic period or not. Results Of 71 patients, 26 underwent a COVID-19 polymerase chain reaction test with clinical suspicion during the pandemic period. Of these 26 patients, 4 were diagnosed with COVID-19. Age of the patients, working status (working/retired), compliance with containment measures against the pandemic, number of BCG courses, adverse effects after BCG therapy and systemic immune-inflammation index, which is an inflammation-related parameter, were not different between groups (P > .05). Neutrophil/lymphocyte ratio was significantly higher in the COVID-19 positive group (P < .05). COVID-19 positivity was higher in age groups 50-64 (6.6%) and 65-80 (5.8%) years than that in similar age groups of the normal population. Conclusion Every effort should be made to administer intravesical BCG treatment in high-risk NMIBC patients even during the pandemic period. However, increased risk of COVID-19 transmission should be kept in mind and protective measures against COVID-19 for healthcare providers and patients before the procedure should be taken optimally. The procedure should be postponed in patients with lymphopenia in recent complete blood count.
- 5 November 2020
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (4)
Can the systemic immune inflammation index be a predictor of BCG response in patients with high‐risk non‐muscle invasive bladder cancer?
Aim We aimed to investigate the predictor role of the systemic immune‐inflammation index (SII) on Bacille Calmette Guerin (BCG) response in patients with high‐risk non‐muscle invasive bladder cancer (NMIBC). Methods A total of 96 patients with high‐risk NMIBC, who received intravesical BCG, were enrolled in the study. BCG responsive group (group 1) and BCG failure group (group 2) were compared in terms of demographic and pathological data, peripheral lymphocyte, neutrophil, and platelet counts, neutrophile lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), SII, recurrence free survival (RFS) and progression free survival (PFS). The prognostic ability of the SII for progression was analyzed with multivariate backward stepwise regression models. Results The mean follow‐up time 34.635±14.7 months. Group 2 had significantly higher SII, peripheral lymphocyte, neutrophil, and platelet counts than group 1. A ROC curve was plotted for the SII to predict the BCG failure and the cut‐off point was calculated as 672.75. Effect of the SII to the model was statistically significant (p=0.003) and a higher SII increased the progression one‐fold. A tumor greater than 30 mm in size and a high SII together increased the progression 3.6 folds. Conclusions The SII might be a successful, non‐invasive and low‐cost parameter for prediction of BCG failure in patients with high‐risk NMIBC. The cut‐off value for SII is 672.75 and above this level BCG failure and progression to MIBC might be anticipated. However, these results should be validated in prospective randomized controlled studies with large patient groups.
- 5 November 2020
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (4)
Can the systemic immune inflammation index be a predictor of BCG response in patients with high‐risk non‐muscle invasive bladder cancer?
Aim We aimed to investigate the predictor role of the systemic immune‐inflammation index (SII) on Bacille Calmette Guerin (BCG) response in patients with high‐risk non‐muscle invasive bladder cancer (NMIBC). Methods A total of 96 patients with high‐risk NMIBC, who received intravesical BCG, were enrolled in the study. BCG responsive group (group 1) and BCG failure group (group 2) were compared in terms of demographic and pathological data, peripheral lymphocyte, neutrophil, and platelet counts, neutrophile lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), SII, recurrence free survival (RFS) and progression free survival (PFS). The prognostic ability of the SII for progression was analyzed with multivariate backward stepwise regression models. Results The mean follow‐up time 34.635±14.7 months. Group 2 had significantly higher SII, peripheral lymphocyte, neutrophil, and platelet counts than group 1. A ROC curve was plotted for the SII to predict the BCG failure and the cut‐off point was calculated as 672.75. Effect of the SII to the model was statistically significant (p=0.003) and a higher SII increased the progression one‐fold. A tumor greater than 30 mm in size and a high SII together increased the progression 3.6 folds. Conclusions The SII might be a successful, non‐invasive and low‐cost parameter for prediction of BCG failure in patients with high‐risk NMIBC. The cut‐off value for SII is 672.75 and above this level BCG failure and progression to MIBC might be anticipated. However, these results should be validated in prospective randomized controlled studies with large patient groups.
- 1 March 2020
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 7 (1) , 27-32
Comparison of Hounsfield Unit and İntraoperative “GATA Scale” Score to Determine Requirement of DJ Stent Insertion in Ureteral Stone Treatment
- 1 March 2020
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 7 (1) , 27-32
Comparison of Hounsfield Unit and İntraoperative “GATA Scale” Score to Determine Requirement of DJ Stent Insertion in Ureteral Stone Treatment